Gravity Branding names Novartis’ Vijoice® (alpelisib)
SAN FRANCISCO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Gravity Branding, the agency behind naming blockbuster drugs including Novartis’ Kisqali® (ribociclib), Genentech’s Herceptin®…
Browsing Tag
Alpelisib
Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination…
– Combination of tipifarnib and alpelisib shows robust activity in preclinical PDX models of HRAS and PIK3CA pathway dependent tumors – – HNSCC accounts for more than 500,000 new cancer…